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Aims
The Intraosseous Transcutaneous Amputation Prosthesis (ITAP) may improve quality of life 
for amputees by avoiding soft-tissue complications associated with socket prostheses and 
by improving sensory feedback and function. It relies on the formation of a seal between the 
soft tissues and the implant and currently has a flange with drilled holes to promote dermal 
attachment. Despite this, infection remains a significant risk. This study explored alternative 
strategies to enhance soft-tissue integration.
Materials and Methods
The effect of ITAP pins with a fully porous titanium alloy flange with interconnected pores 
on soft-tissue integration was investigated. The flanges were coated with fibronectin-
functionalised hydroxyapatite and silver coatings, which have been shown to have an 
antibacterial effect, while also promoting viable fibroblast growth in vitro. The ITAP pins 
were implanted along the length of ovine tibias, and histological assessment was 
undertaken four weeks post-operatively.
Results
The porous titanium alloy flange reduced epithelial downgrowth and increased soft-tissue 
integration compared with the current drilled flange. The addition of coatings did not 
enhance these effects.
Conclusion
These results indicate that a fully porous titanium alloy flange has the potential to increase 
the soft-tissue seal around ITAP and reduce susceptibility to infection compared with the 
current design.
Cite this article: Bone Joint J 2017;99-B:393–400.
The Intraosseous Amputation Prosthesis
(ITAP) (Stanmore Implants Worldwide Ltd,
Elstree, United Kingdom) is an osseo-
integrated, transcutaneous titanium alloy
implant that penetrates the skin to attach an
external prosthesis. It avoids many of the com-
mon problems of conventional socket prosthe-
ses, such as discomfort, excessive perspiration,
pressure sores caused by non-uniform pressure
distribution over the stump and the need for
repeated fittings due to poor fit.1-3 Osseointe-
grated transcutaneous prostheses are able to
avoid these problems because the forces that
would be encountered by the soft tissues of the
stump with the use of a socket prosthesis are
transferred directly to the skeleton.
Achievement of a seal between the soft
tissues and the implant is necessary to avoid
infection. Soft-tissue attachment to the
implant prevents epithelial downgrowth (the
migration of epithelial cells downwards and
parallel to the side of the implant), which may
lead to marsupialisation (pocket-formation)
of the soft tissues and thereby a route for
organisms to enter the underlying soft tis-
sues.4 In order to achieve soft-tissue integra-
tion, fibroblasts must win the ‘race for the
surface’ against bacteria. The ‘race for the
surface’ describes the competition between
eukaryotic cell and bacterial adhesion on the
implant’s surface.5,6 In the case of ITAP, fibro-
blasts need to adhere to the surface before
bacteria. If fibroblasts win the ‘race’, the
implant would be covered by a cellular layer,
making the surface less available for bacterial
attachment. This would lead to successful tis-
sue integration. However, bacteria may win
the ‘race’ establishing biofilm formation,
which may be difficult to eradicate. The cur-
rent ITAP design has a flange with drilled
holes to increase soft-tissue integration. Infec-
tion, nevertheless, remains a risk.
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This study aimed to investigate if surface modifications
and coatings could improve soft-tissue integration by ena-
bling fibroblasts to win the ‘race for the surface’ against
bacteria. Fully porous titanium (i.e. with interconnected
pores) has been shown to increase tissue integration, as
pores allow migration and proliferation of cells, ingrowth
of blood vessels and consequently tissue formation within
the porous structure.7,8 Other osseointegrated prosthetic
designs have shown improvements in soft-tissue integration
with porous-coated implants, but have not eliminated the
problem of marsupialisation.9 A fully porous ITAP flange
has not previously been investigated. Fibronectin-
functionalised hydroxyapatite (HAFn) has been shown to
enhance in vitro fibroblast adhesion and, when applied to
drilled-holed implants, has improved in vivo soft-tissue
integration.10,11 However, it is known that bacteria often
adhere to surfaces that promote soft-tissue integration and
therefore, the presence of an antimicrobial coating during
the early post-operative period before a robust seal has
formed may be of value to prevent bacteria from adhering
before fibroblasts attach. Silver has a broad spectrum of
antimicrobial activity and can be incorporated into
fibronectin-functionalised hydroxyapatite coatings using
an electrochemical deposition technique.12,13 An advantage
of the electrochemical deposition technique is that it may be
used to coat complex structures (such as a porous flange).
More commonly used line-of-sight techniques, such as
plasma spraying, would not be able to do this.14 Fibronec-
tin-functionalised hydroxyapatite coatings with silver
(HAAgFn) have been shown to prevent bacterial colonisa-
tion while promoting viable fibroblast attachment in
vitro.15
The hypothesis of this in vivo study is that a fully porous
ITAP flange would increase soft-tissue integration over the
current drilled-hole design and that HAAgFn coatings
would further increase soft-tissue integration.
Materials and Methods
Transcutaneous pin designs and coatings. Transcutaneous
pins with a laser-sintered porous titanium alloy flange (pore
size 700 μm and strut size 300 μm, porosity 18%) (Eurocoat-
ings, Trentino, Italy) were used (Fig. 1a, Table I). The flanges
were either uncoated (PT) or coated with electrochemically
deposited hydroxyapatite (PT-HA), hydroxyapatite (HA)
with fibronectin (PT-HAFn), HA with silver (PT-HAAg) or
HA with silver and fibronectin (PT-HAAgFn). The details of
the surface preparation and electrochemical deposition pro-
cess is available in the supplementary material. The current
ITAP drilled-flange (DF) design, which consists of a flat
flange with drilled holes (with a diameter of 700 μm) and a
tapered intraosseous stem was used as a control (Fig. 1b,
Table I). The flange and the stem are coated with plasma
sprayed HA (Plasma Biotal Ltd, Buxton, United Kingdom).
An uncoated straight pin (SP) without a flange was included
as a control for the DF design.
Surface characterisation. Scanning electron microscopy
(SEM) was performed to visualise the surface topogra-
phy and morphology of all coatings on the outer surface of
the implants and to measure the thickness of HA and
HAAg coatings on the outer surface of the implant and
within the central pores. Energy-dispersive X-ray spectros-
copy analysis was performed to determine the Ca/P ratio of
HA coatings and to measure the atomic percentage of Ag
within coatings. A full description of this technique is avail-
able in the supplementary material.
Silver release. The amount of silver released into fetal calf
serum from PT-HAAg was measured over a four-week
Table I. Transcutaneous flanged-pin dimensions
Dimension (mm) PT DF
Total pin length 45 47
Length of transcutaneous portion 19.2 17
Length of intraosseous portion 21.5 29
Flange length 4.3 1
Pin diameter 5 5
Flange diameter 11 11
Thread pitch 0.8 -
Core diameter 4.2 -
PT, porous titanium alloy flange; DF, drilled flange
Fig. 1a
Diagrams showing an Intraosseous Amputation Prosthesis
pin with a (a) porous titanium alloy flange and (b) drilled
flange.
Fig. 1b
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period, with PT-HA used as a control. The flanges were
placed in 5 mL of fetal calf serum at room temperature.
Flanges were removed at four, eight and 24 hours and then
on days 2, 3, 4, 5, 8, 11, 14, 18 and 28. Flanges were placed
into fresh fetal calf serum solution at each time point.
Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
(Trace Element Laboratory, London, United Kingdom) was
used to quantify the silver content in elution fluids.
Animal model. The study was performed under a Project
License and a Personal License according to the United
Kingdom Home Office Scientific Procedures Act 1986.
Skeletally mature female sheep (mules) (n = 6) weighing
between 66 kg and 88 kg were used. Transcutaneous pins
were implanted along the length of the sheep tibia. Details
of the surgical procedure are included in the supplementary
material.
Hard grade resin-histological processing. The specimens were
fixed in 10% formal saline. Following this, they underwent
ascending graded alcohol dehydration and defatting in chlo-
roform. They were embedded in LR White Resin (London
Resin Company Ltd, Reading, United Kingdom). The histo-
logical sectioning process is described in the supplementary
material.
Hard grade resin-histological analysis. Two sections were
analysed for each implant. The following outcomes were
measured:
- epithelial downgrowth (mm)
- percentage epithelial attachment
- percentage dermal attachment.
A line intercept method was used for these measurements
(Fig. 2).4 The thickness of the epithelial and dermal tissue
layers was measured and expressed as a percentage of the
thickness of these layers in contact with the implant sur-
face.
A semi-quantitative estimate was used to express the per-
centage of the pore filled with soft tissue and the density of
the tissue within the pore compared with that outside it.
Fibroblast nuclei within the inner pores were counted
within a defined area and the number per mm2 calculated.
The blood vessels within the inner pores were counted
within a defined area and number of blood vessels per mm2
was calculated.
Statistical analysis. This was performed using SPSS version
21.0 software (IBM, Armonk, New York). The Kruskal-
Wallis test was used to identify differences between groups.
Paired Mann-Whitney U tests were used to determine dif-
ferences between implant types. A p-value < 0.05 was con-
sidered statistically significant. Data are presented as
median values and 95% confidence intervals (CI).
Results
Surface characterisation-surface topography, coating thickness
and elemental composition. The electrochemically deposited
coatings on the porous titanium alloy flanges contained a
combination of plate-like, needle-shaped and globular crystals
similar to that observed on solid discs in previous in vitro stud-
ies.15 SEM images are shown in Figure 3.
The median calcium:phosphate atomic percentage ratio
for electrochemically deposited HA coatings was 1.74
(95% CI 1.62 to 1.86). This indicated that these HA coat-
ings were close in composition to pure stoichiometric HA.
The thickness of coatings is presented in Table II. Table III
shows the silver atomic percentages of HAAg/Fn coatings.
Silver release. The silver release was greatest over the first
24 hours, and gradually reduced over time (4.14 μmol/L at
28 days). The rate of release was slowest between days 11
and 28. Silver continued to be released throughout the 28-
day test period (Table IV).
Soft-tissue integration-epithelial downgrowth. SP resulted
in the greatest degree of epidermal downgrowth. DF reduced
epithelial downgrowth compared with SP (DF = 4.2 mm,
SP = 6.1 mm; Mann-Whitney U test, p < 0.001). PT reduced
epithelial downgrowth compared with DF (Mann-Whitney U
test, p = 0.027). The addition of coatings to PT did not result
Fig. 2
Schematic diagram showing the measurements for epithelial downgrowth, epithelial and
subepithelial attachment for a flanged implant.
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in any further reduction in epidermal downgrowth. PT-
HAFn, PT-HAAg and PT-HAAgFn reduced epidermal
downgrowth compared with DF (Mann-Whitney U test,
p = 0.003, p = 0.017 and p = 0.001 respectively). The
reduction in epidermal downgrowth conferred by the PT-
HA coating compared with DF did not reach statistical sig-
nificance (Mann-Whitney U test, p = 0.052) (Table V).
Soft-tissue integration-percentage epithelial attachment. The
epithelium did not attach to the SP and this implant was there-
fore associated with the lowest median percentage epithelial
attachment (0%, interquartile range (IQR) 0% to 0%). The
DF had a greater median percentage epithelial attachment,
which was highly variable between implants (63.4%, IQR 0%
to 100%) (Mann-Whitney U test, p = 0.045). There was no
Fig. 3a
Scanning electron micrographs of (a) the outer surface of a hydroxyapatite (HA) with silver and fibronectin-coated implant (× 50
magnification) and (b) a section through the centre of a hydroxyapatite coated implant (PT) showing the coating on the innermost
pores.
Fig. 3b
Table II. Thickness of coatings
Surface Coating thickness (μm) median value (95% confidence interval)
PT-HA (outer surface) 47 (30 to 76)
PT-HA (inner pores) 36 (12 to 55)
PT-HAAg (outer surface) 56 (24 to 101)
PT-HAAg (inner pores) 46 (31 to 82)
PT-HA, hydroxyapatite coated flange; PT-HAAg, hydroxyapatite with silver coated flange
Table III. Silver percentages within PT-HAAg and PT-HAAgFn coatings measured by energy-
dispersive X-ray spectroscopy analysis
Surface Ag atomic % median value (95% confidence interval)
PT-HAAg 0.700 (0.582 to 0.757) 
PT-HAAgFn 0.610 (0.591 to 0.652) 
PT-HAAg, hydroxyapatite with silver coated flange; PT-HAAgFn, hydroxyapatite with silver 
and fibronectin coated flange
Table IV. The release of silver from hydroxyapatite with silver coated flange over 28 days
Time (days) Silver release (umol/L) median value (95% confidence interval)
1 101.5810 (46.7192 to 163.9788)
2 27.6840 (0.5311 to 60.5682)
3 21.9790 (3.5346 to 43.1121)
4 23.5450 (3.5155 to 40.7465)
5 19.4430 (6.0237 to 31.2776)
8 12.1270 (-1.5545 to 27.2212)
11 5.3860 (2.6626 to 7.5661)
14 4.3950 (1.4158 to 6.5149)
18 3.5550 (0.6460 to 5.4300)
28 4.1400 (-1.0457 to 7.7223) 
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difference between DF and PT implants, irrespective of coat-
ing (Kruskal-Wallis test, p = 0.859).
Soft-tissue integration-percentage dermal attachment. The
DF showed greater median dermal attachment than the SP
(DF = 56.4%, SP = 0%; Mann-Whitney U test, p = 0.017).
The PT component had greater median dermal attachment
than DF (PT = 80.5%; Mann-Whitney U test, p = 0.020),
with the addition of coatings conferring no statistically sig-
nificant improvements in dermal attachment. Improved
attachment was seen in PT-HAFn compared with PT-HA
(Mann-Whitney U test, p = 0.023) and in PT-HAAgFn com-
pared with PT-HAAg (Mann-Whitney U test, p = 0.039)
(Fig. 4). Histological sections are shown in Figure 5.
Soft-tissue integration-percentage soft-tissue fill. The
median percentage soft-tissue fill within the inner pores of
PT was significantly greater than that of the DF (PT = 90%,
DF = 65%; Mann-Whitney U test, p < 0.001). The addition
of coatings did not result in any increases in percentage
soft-tissue fill (Table VI). Histological sections are shown in
Figure 5.
Soft-tissue integration-number of cell nuclei/mm2. There was
a greater median density of cell nuclei within the inner pores of
the PT flange than the DF (PT = 3922.6 mm2, DF = 1520.5
mm2; Mann-Whitney U test, p = 0.018). The addition of coat-
ings was not associated with any change in density (Table VII).
Soft-tissue integration-number of blood vessels/mm2. There
was a greater median density of blood vessels within the
inner pores of the PT flange than the DF (PT = 213.2 mm2,
DF = 0 mm2; Mann-Whitney U test, p = 0.002). Coatings did
not result in further increases in blood vessel ingrowth.
Discussion
This study has shown for the first time that using a PT
flange reduces epithelial downgrowth and increases dermal
attachment and ingrowth of vascularised soft tissue into
pores when compared with the standard drilled-hole ITAP
flange. Other studies of the effect of porous titanium alloy
on soft-tissue integration of transcutaneous pins have used
porous coatings rather than a fully porous material, have
assessed smaller pore sizes and have made comparisons with
smooth implants rather than drilled-hole implants.9,16,17
The coatings did not show any statistically significant
advantages over PT. The median dermal attachment of PT
was 80% and the median soft-tissue fill was 90%. It may be
difficult to achieve significant improvements or complete
soft-tissue attachment with the animal model used in this
study. In this study, the sheep were mobilised bearing full
weight from the first post-operative day, which would cre-
ate some movement at the skin-implant interface before the
seal could form. In clinical practice in humans, there is a
rest period where the implant is not loaded during the early
wound-healing period. Increased bacterial exposure is also
likely in an animal model, however, the sheep may have a
higher resistance to bacterial infections than humans.
Although there were no statistically significant differ-
ences when coatings were added to PT, PT-HA lost some of
the beneficial effects associated with PT. The reduction in
epithelial downgrowth associated with PT-HA compared
with DF was not statistically significant. PT with all other
coatings significantly reduced epithelial downgrowth.
Additionally, PT-HA was the only PT implant not associ-
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Fig. 4
Box-and-whisker plot showing the percentage dermal attachment to implants (SP,
straight pin; DF, drilled flange; PT, uncoated porous titanium alloy flange; PT-HA,
hydroxyapatite coated flange; PT-HAFn, hydroxyapatite with fibronectin coated flange;
PT-HAAg, hydroxyapatite with silver coated flange; PT-HAAgFn, hydroxyapatite with sil-
ver and fibronectin coated flange).
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ated with significantly improved blood vessel ingrowth
compared with DF. The negative effect of HA may be due to
increased bacterial colonisation when this coating is used
on porous titanium, permitting bacteria to win the ‘race for
the surface’.15 PT-HAFn did not have a negative effect
although, similarly to HA, HAFn would be expected to
promote adhesion of some bacterial strains.18-20 It is possi-
ble that when fibronectin is added to HA, despite its poten-
tial to increase bacterial colonisation, cells are able to win
the ‘race for the surface’ due to early soft-tissue adherence
allowing HAFn to overcome any loss of beneficial effects
associated with HA.
Silver release was sustained over the 28 days at a slow
rate indicating that the coating persists for 28 days. These
were below levels that would cause systemic toxicity.21 The
levels released remained above those shown to have bacte-
ricidal activity in vitro.12 HAAg coatings did not produce
any adverse soft-tissue reactions suggesting that the levels
of silver were safe. PT-HAAg was associated with increased
vascularisation within the inner pores compared with PT-
HA. Additionally, PT-HAAg/Fn maintained the beneficial
effects that PT had on epithelial downgrowth and vascular-
ity over DF that PT-HA had lost. This indicates that silver
had some effect. The effect of silver coatings without HA or
increasing the concentration of silver may have a different
effect. It is possible that, despite not having a significant
effect on soft-tissue attachment, silver could reduce bacte-
rial colonisation, which could be of value in terms of pre-
venting infection. If this were to be the case, the fact that
this study has shown that there is no adverse soft-tissue
reaction associated with silver, would be useful. Further
data on bacterial colonisation on the implant surfaces in
this study will be published separately.
It has been previously shown that if dermal attach-
ment is achieved even without epithelial attachment, epi-
thelial downgrowth is inhibited.4 Once epithelial
downgrowth is prevented and keratinocytes in the epi-
thelium come into contact with the implant surface, they
may attach via hemidesmosomes and allow an epithelial
seal to form in addition to the dermal seal.4,22,23 The
porous flanges did not, however, significantly increase
epithelial attachment, despite the increase in dermal
attachment. Design modifications to increase epithelial
attachment may be necessary, such as coating the trans-
cutaneous portion of the implant with proteins that
enhance keratinocyte attachment.23
Fig. 5a
Histological sections showing (a) incomplete soft-tissue fill within a drilled flange (DF) pore (P); (b) areas of lack of the dermal tissue
(D) attachment to the flange of a DF implant (arrows); (c) intimate contact between uncoated porous titanium alloy flange (PT) pore
edges and soft-tissue PT. Increased collagen deposition is seen at the pore periphery and (d) the dermis attaching to hydroxyapatite
with fibronectin coated flange flange.
Fig. 5b
Fig. 5c Fig. 5d
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There are several potential limitations of this study.
Firstly, we measured soft-tissue contact rather than
mechanical strength of attachment. However, other studies
that have performed mechanical testing have shown that
the histological findings support strength of attachment
results.24,25 Secondly, the time period of four weeks for this
study was short. It is known that as time increases soft-
tissue attachment increases.24,26 The short time period
which was selected as an assessment of early attachment is
essential, as early soft-tissue attachment is the key factor
affecting the outcome of the ‘race for the surface’.5,6 Longer
periods of time would also make quantification of cell
nuclei density challenging due to the proliferation of nuclei.
Although the main intended application of the findings
from this research is for improving the success of ITAP, the
findings could also be applied to other transcutaneous
devices. For example, the addition of a porous flange to
external fixator pins may have the potential to reduce infec-
tion rates by improving soft-tissue integration at the skin–
implant interface. Furthermore, the coating HAAgFn may
be more likely to produce favourable in vivo results for
osseointegration than for soft-tissue integration due to the
rough topography. Further investigation of porous metals
coated with electrochemically deposited HAAg (with and
without fibronectin) to assess the effect on osseointegration
would be useful to determine if these coatings could play a
role in preventing loosening and bacterial colonisation of
the intraosseous portion of ITAP or for uncemented arthro-
plasty surgery. Additionally, this coating technique could be
applied to endoprosthetic replacements with porous collars
e.g. for tumour resection.
In conclusion, the results of this study indicate that a PT
flange, without the addition of coatings, has the potential
to increase the soft-tissue seal around ITAP, which would be
expected to reduce the susceptibility of ITAP to infection
compared with the current drilled-hole flange design.
Further investigation of fibronectin and silver coatings
without HA may be of value.
Table V. Epithelial downgrowth measurements associated with each implant
Surface Epithelial downgrowth (mm) median value (95% confidence interval)
Straight pin 6.0753 (5.2082 to 8.7915)
DF 4.2043 (2.6040 to 4.3087)
PT 1.2900 (0.9936 to 3.1139)
PT-HA 1.7826 (1.2789 to 3.3195)
PT-HAFn 1.7655 (1.2074 to 2.3601)
PT-HAAg 1.7562 (0.9242 to 2.9181)
PT-HAAgFn 1.7888 (1.3366 to 2.1510)
DF, drilled flange; PT, uncoated porous titanium alloy flange; PT-HA, hydroxyapatite coated flange; PT-HAFn, hydroxyapatite with 
fibronectin coated flange; PT-HAAg, hydroxyapatite with silver coated flange; PT-HAAgFn, hydroxyapatite with silver and 
fibronectin coated flange
Table VI. Number of cell nuclei/mm2 within the inner pores of each implant
Surface Cell nuclei/mm2median value (n, 95% confidence interval)
DF 1520.5050 (1028.8516 to 2332.6951)
PT 3922.6250 (2590.6413 to 5182.6021)
PT-HA 2883.8250 (2029.4570 to 3891.7696)
PT-HAFn 2945.8300 (2473.5655 to 3708.2709)
PT-HAAg 3086.2450 (2595.8449 to 4017.1911)
PT-HAAgFn 2606.3700 (1990.1559 to 4334.6132)
DF, drilled flange; PT, uncoated porous titanium alloy flange; PT-HA, hydroxyapatite coated 
flange; PT-HAFn, hydroxyapatite with fibronectin coated flange; PT-HAAg, hydroxyapatite 
with silver coated flange; PT-HAAgFn, hydroxyapatite with silver and fibronectin coated 
flange
Table VII. Number of cell nuclei/mm2 within the inner pores of each implant
Surface Cell nuclei/mm2median value (n, 95% confidence interval)
DF 1520.5050 (1028.8516 to 2332.6951)
PT 3922.6250 (2590.6413 to 5182.6021)
PT-HA 2883.8250 (2029.4570 to 3891.7696)
PT-HAFn 2945.8300 (2473.5655 to 3708.2709)
PT-HAAg 3086.2450 (2595.8449 to 4017.1911)
PT-HAAgFn 2606.3700 (1990.1559 to 4334.6132)
DF, drilled flange; PT, uncoated porous titanium alloy flange; PT-HA, hydroxyapatite coated 
flange; PT-HAFn, hydroxyapatite with fibronectin coated flange; PT-HAAg, hydroxyapatite 
with silver coated flange; PT-HAAgFn, hydroxyapatite with silver and fibronectin coated 
flange
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Take home message:
- A fully porous titanium alloy flange with interconnected
pores improves soft-tissue integration. It reduces epithelial
downgrowth and increases dermal attachment, cell nuclei density and
blood vessel ingrowth compared with the current standard ITAP model.
- The addition of hydroxyapatite, silver and fibronectin coatings did not
significantly improve soft-tissue integration.
- It is therefore postulated that a fully porous titanium alloy flange, with-
out the addition of coatings, has the potential to reduce the susceptibility
of ITAP to infection by increasing soft-tissue integration.
Supplementary material
Further information regarding the surface prepara-
tion, the surgical details and the histological section
is included alongside the online version of this article at
www.bjj.boneandjoint.org.uk.
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